As of Q4'25 (2025-12-28), Johnson & Johnson reported Operating Cash Flow of $7.3B and Free Cash Flow of $5.47B. Both metrics showed a notable increase from the previous quarter, with Operating Cash Flow rising from $3.88B and Free Cash Flow from $2.84B in Q2'25. Over the period from Q1'23 to Q4'25, the chart reveals a generally volatile but upward trend in both Operating and Free Cash Flow, punctuated by significant spikes in Q3 of each year—most notably, Operating Cash Flow peaked at $9.17B and Free Cash Flow at $8.01B in Q3'25. Despite some fluctuations, both cash flow figures have demonstrated resilience and growth, particularly in the latter quarters, indicating strong underlying cash generation capabilities.